drug

(netupitant + palonosetron hydrochloride)

Marketedupdated 3mo ago

by Helsinn Therapeutics (US) Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying (netupitant + palonosetron hydrochloride)

phase1A Clinical Trial to Assess Safety and Pharmacokinetics of Fosnetupitant 235 mg and Metabolites in Healthy Volunteersterminatedn=50
phase2Prevention of Breakthrough CINV in Patients Receiving Moderately or Highly Emetogenic Chemotherapyunknownn=100

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 15m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

(netupitant + palonosetron hydrochloride)

Marketedupdated 3mo ago

by Helsinn Therapeutics (US) Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying (netupitant + palonosetron hydrochloride)

phase1A Clinical Trial to Assess Safety and Pharmacokinetics of Fosnetupitant 235 mg and Metabolites in Healthy Volunteersterminatedn=50
phase2Prevention of Breakthrough CINV in Patients Receiving Moderately or Highly Emetogenic Chemotherapyunknownn=100

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 15m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

(netupitant + palonosetron hydrochloride)

all catalysts(0)

Trials studying (netupitant + palonosetron hydrochloride)

News(0)

Report a data issue

comments(0)

(netupitant + palonosetron hydrochloride)

all catalysts(0)

Trials studying (netupitant + palonosetron hydrochloride)

News(0)

Report a data issue

comments(0)